Cargando…
Inhibition of retinoic acid receptor β signaling confers glycolytic dependence and sensitization to dichloroacetate in melanoma cells
Dysregulation of metabolism during melanoma progression is tightly associated with the acquisition of genetic and epigenetic alterations in regulators of metabolic pathways. Retinoic acid receptor beta (RARβ) is epigenetically silenced in a large proportion of melanomas, but a link between RARβ and...
Autores principales: | Abildgaard, Cecilie, Dahl, Christina, Abdul-Al, Ahmad, Christensen, Annette, Guldberg, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663589/ https://www.ncbi.nlm.nih.gov/pubmed/29137417 http://dx.doi.org/10.18632/oncotarget.20476 |
Ejemplares similares
-
Bioenergetic modulation with dichloroacetate reduces the growth of melanoma cells and potentiates their response to BRAF(V600E) inhibition
por: Abildgaard, Cecilie, et al.
Publicado: (2014) -
Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma
por: Abildgaard, Cecilie, et al.
Publicado: (2021) -
Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene
por: Hall, Arnaldur, et al.
Publicado: (2013) -
Long-term stabilization of metastatic melanoma with sodium dichloroacetate
por: Khan, Akbar, et al.
Publicado: (2017) -
Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma
por: Li, Chunyan, et al.
Publicado: (2014)